glp 1 drugs and antidepressants Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports New study: antidepressant use and
Description
Cross-species pharmacokinetics shift with body mass, enzymatic clearance, and protein binding

Provider reviews (may request a video consult)

Y., Yazici, D., Pizzagalli, D

When combined with medical supervision, these benefits contribute to steady, sustainable weight loss rather than rapid short-term changes followed by regain

Due to the limited sample size, larger studies are required to validate these findings

J Clin Invest 1993;91:3017.ArticlePubMedPMC 56
